Michael Gillen Selected Research

verinurad

1/2019	Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Administration of Verinurad and Febuxostat in Healthy Male Volunteers.
8/2018	Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Verinurad, a Selective Uric Acid Reabsorption Inhibitor.
1/2018	Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Multiple Dose Administration of Verinurad (RDEA3170) and Allopurinol in Adult Male Subjects With Gout.
1/2018	Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy Japanese and non-Asian male subjects.
1/2018	Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label study.
1/2018	Metabolism and Disposition of Verinurad, a Uric Acid Reabsorption Inhibitor, in Humans.
1/2018	Verinurad combined with febuxostat in Japanese adults with gout or asymptomatic hyperuricaemia: a phase 2a, open-label study.
1/2018	Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label study.
1/2017	Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy adult male subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Gillen Research Topics

Disease

16	Gout 01/2019 - 01/2016
10	Hyperuricemia 01/2019 - 01/2017
8	Asthma (Bronchial Asthma) 06/2021 - 05/2008
8	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 11/2008
1	Proteinuria 04/2024
1	Chronic Renal Insufficiency 04/2024
1	Body Weight (Weight, Body) 01/2018
1	Rheumatoid Arthritis 12/2015
1	Heart Failure 12/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2015
1	Rhinitis 10/2002
1	Seasonal Allergic Rhinitis (Hay Fever) 10/2002

Drug/Important Bio-Agent (IBA)

14	Uric Acid (Urate)IBA 01/2019 - 01/2016
9	verinuradIBA 01/2019 - 01/2017
7	lesinuradIBA 01/2019 - 01/2016
6	Budesonide (Pulmicort)FDA LinkGeneric 01/2020 - 05/2008
6	Xanthine OxidaseIBA 01/2019 - 01/2016
5	Formoterol Fumarate (Oxis)FDA Link 01/2020 - 11/2008
4	SuspensionsIBA 06/2021 - 01/2018
4	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2021 - 01/2018
3	budesonide-glycopyrrolate-formoterol fumarate drug combinationIBA 10/2020 - 01/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 05/2008
2	Colchicine FDA LinkGeneric 01/2018 - 07/2017
2	Febuxostat FDA Link 01/2018 - 01/2018
2	Allopurinol (Remid)FDA LinkGeneric 01/2018 - 01/2018
1	Endothelin A ReceptorIBA 04/2024
1	ZD4054IBA 04/2024
1	SodiumIBA 04/2024
1	Glucose (Dextrose)FDA LinkGeneric 04/2024
1	dapagliflozinIBA 04/2024
1	Albuterol (Salbutamol)FDA LinkGeneric 06/2021
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2021
1	Muscarinic AntagonistsIBA 01/2020
1	AntacidsIBA 01/2019
1	AnticoagulantsIBA 01/2019
1	Warfarin (Coumadin)FDA LinkGeneric 01/2019
1	coumarinIBA 01/2019
1	BenzbromaroneIBA 01/2018
1	Indomethacin (Indometacin)FDA LinkGeneric 07/2017
1	Naproxen (Naprosyn)FDA LinkGeneric 07/2017
1	AZD1981IBA 01/2017
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2017
1	Syk KinaseIBA 12/2015
1	Digoxin (Digitek)FDA LinkGeneric 12/2015
1	fostamatinibIBA 12/2015
1	Bronchodilator Agents (Bronchodilators)IBA 03/2014
1	Methacholine Chloride (Methacholine)FDA Link 04/2011
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 05/2008
1	AllergensIBA 10/2002
1	ebastine (Kestin)IBA 10/2002

Therapy/Procedure

8	Metered Dose Inhalers (Metered Dose Inhaler) 10/2020 - 11/2008
3	Therapeutics 10/2020 - 11/2008
3	Dry Powder Inhalers 01/2020 - 05/2008
1	Inhalation Spacers 01/2018